VYNE THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.35 USD | +4.44% |
|
-8.56% | +0.86% |
| Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
| Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar VYNE Therapeutics Inc.
0c6babaa1e6.KqsUPPnzJI2HhB6D6f3z91ITLxaz0PEEam1O03RwPXY.bppLcc3HR8q-wW3W3oSwoA0-HHL6_chQGCMHpitDbiZcn3Vvi95-xLT1Uw~61c4b7834a24a28fbbafc3478b9e097d
Upcoming events on VYNE Therapeutics Inc.
Past events on VYNE Therapeutics Inc.
| 2024-03-28 08:30 am | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 2024-03-07 12:06 pm | Global Vitiligo Foundation Scientific Symposium |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-29 08:00 am | Q4 2023 Earnings Release |
| 2023-12-13 10:00 am | Annual General Meeting |
| 2023-11-13 07:45 am | Q3 2023 Earnings Release |
| 2023-11-09 01:30 pm | R&D Day |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Release |
| 2023-06-04 | BIO International Convention |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-03-30 03:30 pm | H.C. Wainwright Autoimmune & Inflammatory Disease Conference |
| 2023-03-09 04:01 pm | Q4 2022 Earnings Release |
| 2023-03-07 02:10 pm | Cowen Health Care Conference |
| 2023-01-12 10:00 am | Extraordinary Shareholders Meeting |
| 2023-01-09 | LifeSci Partners Corporate Access Conference |
| 2023-01-09 | JP Morgan Healthcare Conference |
| 2022-12-08 10:00 am | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference |
| 2022-12-01 12:30 pm | Piper Sandler Healthcare Conference |
| 2022-11-10 04:01 pm | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,44 2,34 -81.04% | 21,0 21,7 -3.3% | 14,8 17,3 -14.51% | 0,48 0,37 30.09% | 0,42 0,50 -15.2% | 0,40 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -29,3 -29,7 1.49% | -35,0 |
|
EBIT Million USD | Released Forecast Spread | -95,9 -99,9 3.98% | -253 -190 -32.84% | -68,0 -65,9 -3.17% | -34,3 -36,6 6.17% | -29,3 -32,2 9% | -35,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -95,4 -99,3 3.97% | -256 -259 1.04% | -73,8 -72,2 -2.26% | -33,9 -30,3 -12.17% | -27,9 -28,7 2.89% | -33,5 |
|
Net income Million USD | Released Forecast Spread | -95,2 -99,3 4.15% | -256 -258 1.03% | -73,3 -72,2 -1.63% | -23,2 -23,8 2.27% | -28,5 -28,7 0.86% | -33,5 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -142 -121 -17.32% | -25,6 -24,7 -3.4% | -7,28 -8,52 14.55% | -2,78 -4,82 42.32% | -1,00 |
| Announcement Date | 12/03/20 | 04/03/21 | 17/03/22 | 09/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,29 4,12 -44.37% | 0,18 0,37 -51.45% | 0,13 0,10 26% | 0,17 0,05 234% | 0,01 0,06 -90% | 0,10 0,00 - | 0,14 0,05 170% | 0,11 0,15 -24% | 0,08 0,15 -49.33% | 0,10 | 0,11 | 0,11 | 0,13 |
|
EBITDA Million USD | Released Forecast Spread | -10,8 | -7,30 | -8,10 | -8,50 | -8,90 | -9,50 | |||||||
|
EBIT Million USD | Released Forecast Spread | -12,0 -13,4 10.12% | -8,69 -8,67 -0.28% | -8,29 -9,77 15.15% | -9,33 -10,3 8.95% | -7,98 -10,3 22.49% | -5,88 -8,45 30.47% | -10,3 -10,6 2.66% | ||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,0 -13,5 10.65% | -8,69 -8,90 2.31% | -8,24 -10,3 20.05% | -9,26 -8,90 -3.99% | -7,75 -10,6 26.56% | -5,61 -8,40 33.19% | -10,0 -8,70 -15.38% | -6,07 -10,6 42.73% | -6,15 -7,00 12.11% | -7,80 | -8,20 | -8,50 | -9,10 |
|
Net income Million USD | Released Forecast Spread | -11,6 -13,5 13.98% | 4,67 -8,90 152.47% | -8,48 -10,3 17.71% | -9,46 -8,90 -6.28% | -9,95 -10,6 5.73% | -5,62 -8,40 33.07% | -10,1 -8,70 -15.61% | -6,58 -10,6 37.89% | -6,19 -7,00 11.6% | -7,79 | -8,20 | -8,50 | -9,10 |
|
EPS USD | Released Forecast Spread | -3,96 -4,50 12% | 1,44 -2,94 148.98% | -2,70 -3,24 16.67% | -2,88 -2,82 -2.13% | -3,33 -3,24 -2.78% | -1,74 -2,61 33.33% | -3,09 -2,58 -19.77% | -2,01 -0,76 -164.47% | -0,20 -0,50 60% | -0,24 | -0,25 | -0,25 | -0,27 |
| Announcement Date | 17/03/22 | 12/05/22 | 12/08/22 | 10/11/22 | 09/03/23 | 11/05/23 | 14/08/23 | 13/11/23 | 29/02/24 | - | - | - | - |
More events
Past sector events for VYNE Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VYNE Stock
- Calendar VYNE Therapeutics Inc.
